{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T10:41:36Z","timestamp":1782297696690,"version":"3.54.5"},"reference-count":10,"publisher":"Digital Journal of Opthalmology","issue":"1","license":[{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digit J Ophthalmol"],"abstract":"<jats:p>A 76-year-old man presented with reduced visual acuity in both eyes, more severe in the right eye. His previous medical history included anti\u2013vascular endothelial growth factor treatment, with multiple intravitreal injections in both eyes, and repeated focal laser in the left eye. His best-corrected visual acuity was 20\/200 in the right eye and 20\/40 in the left eye. Based on fundus examination and multimodal imaging, the patient was diagnosed with pachychoroid disease with peripapillary pachychoroid syndrome in the right eye and nasal macular scarring with late cystoid degeneration in the left eye. He underwent low-fluence photodynamic therapy in both eyes. At 6 months\u2019 follow-up, best-corrected visual acuity improved to 20\/120 in the right eye and was maintained at 20\/40 in the left eye, with good anatomical outcome.<\/jats:p>","DOI":"10.5693\/djo.02.2021.11.001","type":"journal-article","created":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T14:47:15Z","timestamp":1651762035000},"page":"7-11","source":"Crossref","is-referenced-by-count":6,"title":["Photodynamic therapy for peripapillary pachychoroid syndrome\u2014a case report"],"prefix":"10.5693","volume":"28","author":[{"given":"George J.","family":"Manayath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shishir","family":"Verghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratnesh","family":"Ranjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkatapathy","family":"Narendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3822","published-online":{"date-parts":[[2022,1,27]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1097\/IAE.0000000000001907","article-title":"Peripapillary pachychoroid syndrome","volume":"38","author":"Phasukkijwatana","year":"2018","unstructured":"1. Phasukkijwatana N, Freund KB, Dolz-Marco R, et al. Peripapillary pachychoroid syndrome. Retina 2018;38:1652-67.","journal-title":"Retina"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.survophthal.2012.07.004","article-title":"Central serous chorioretinopathy: update on pathophysiology and treatment","volume":"58","author":"Nicholson","year":"2013","unstructured":"2. Nicholson B, Noble J, Forooghian F, Meyerle C. Central serous chorioretinopathy: update on pathophysiology and treatment. Surv Ophthalmol 2013;58:103-26.","journal-title":"Surv Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Ma J, Meng N, Xu X, Zhou F, Qu Y. System review and meta-analysis on photodynamic therapy in central serous chorioretinopathy. Acta Ophthalmol (Copenh) 2014;92:e594-601.","DOI":"10.1111\/aos.12482"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41433-018-0158-4","article-title":"Pachychoroid disease","volume":"33","author":"Cheung","year":"2019","unstructured":"4. Cheung CMG, Lee WK, Koizumi H, Dansingani K, Lai TYY, Freund KB. Pachychoroid disease. Eye (Lond) 2019;33:14-33.","journal-title":"Eye (Lond)"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1016\/j.ophtha.2008.08.026","article-title":"Subthreshold diode micropulse photocoagulation for the treatment of chronic central serous chorioretinopathy with juxtafoveal leakage","volume":"115","author":"S-N","year":"2008","unstructured":"5. Chen S-N, Hwang J-F, Tseng L-F, Lin C-J. Subthreshold diode micropulse photocoagulation for the treatment of chronic central serous chorioretinopathy with juxtafoveal leakage. Ophthalmology 2008;115:2229-34.","journal-title":"Ophthalmology"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1097\/IAE.0b013e318297a07a","article-title":"Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study","volume":"33","author":"Bousquet","year":"2013","unstructured":"6. Bousquet E, Beydoun T, Zhao M, Hassan L, Offret O, Behar-Cohen F. Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study. Retina 2013;33:2096-102.","journal-title":"Retina"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4103\/2008-322X.180700","article-title":"Intravitreal bevacizumab for treatment of central serous chorioretinopathy","volume":"11","author":"Unl\u00fc","year":"2016","unstructured":"7. Unl\u00fc C, Erdogan G, Aydogan T, et al. Intravitreal bevacizumab for treatment of central serous chorioretinopathy. J Ophthalmic Vis Res 2016;11:61.","journal-title":"J Ophthalmic Vis Res"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.oftal.2020.01.013","article-title":"Diagnosis by multimodal imaging in peripapillary pachychoroid syndrome: a case report","volume":"95","author":"Alonso-Mart\u00edn","year":"2020","unstructured":"8. Alonso-Mart\u00edn B, de-Lucas-Viejo B, Gimeno-Carrero M, Ferro-Osuna M, Sambricio J. Diagnosis by multimodal imaging in peripapillary pachychoroid syndrome: a case report. Arch Soc Esp Oftalmol Engl Ed 2020;95:248-53.","journal-title":"Arch Soc Esp Oftalmol Engl Ed"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1136\/bjophthalmol-2016-308921","article-title":"Structural analyses of choroid after half-dose verteporfin photodynamic therapy for central serous chorioretinopathy","volume":"101","author":"Izumi","year":"2017","unstructured":"9. Izumi T, Koizumi H, Maruko I, et al. Structural analyses of choroid after half-dose verteporfin photodynamic therapy for central serous chorioretinopathy. Br J Ophthalmol 2017;101:433-7.","journal-title":"Br J Ophthalmol"},{"key":"ref9","unstructured":"10. Lai TYY, Wong RLM, Chan W-M. Long-term outcome of half-dose verteporfin photodynamic therapy for the treatment of central serous chorioretinopathy (an American Ophthalmological Society Thesis). Trans Am Ophthalmol Soc 2015;113:T8."}],"container-title":["Digital Journal of Ophthalmology"],"original-title":[],"link":[{"URL":"https:\/\/djo.harvard.edu\/index.php\/djo\/article\/download\/55\/54","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/djo.harvard.edu\/index.php\/djo\/article\/download\/55\/54","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T13:23:19Z","timestamp":1680700999000},"score":1,"resource":{"primary":{"URL":"https:\/\/djo.harvard.edu\/index.php\/djo\/article\/view\/55"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,27]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,3,31]]}},"URL":"https:\/\/doi.org\/10.5693\/djo.02.2021.11.001","relation":{},"ISSN":["1542-8958"],"issn-type":[{"value":"1542-8958","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,27]]}}}